M.A. Lazzari

2.1k total citations
95 papers, 1.5k citations indexed

About

M.A. Lazzari is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, M.A. Lazzari has authored 95 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 30 papers in Cardiology and Cardiovascular Medicine and 14 papers in Immunology. Recurrent topics in M.A. Lazzari's work include Platelet Disorders and Treatments (39 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). M.A. Lazzari is often cited by papers focused on Platelet Disorders and Treatments (39 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). M.A. Lazzari collaborates with scholars based in Argentina, United States and United Kingdom. M.A. Lazzari's co-authors include Susana Meschengieser, Adriana Inés Woods, Analía Sánchez‐Luceros, A Blanco, Carlos Fondevila, María Teresa Santarelli, Mirta Schattner, Ana Catalina Kempfer, Patricia Casais and M.F. Gimeno and has published in prestigious journals such as Blood, Biochemical Journal and Diabetologia.

In The Last Decade

M.A. Lazzari

89 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Lazzari Argentina 23 623 415 265 236 225 95 1.5k
Abraham Majluf‐Cruz Mexico 19 369 0.6× 164 0.4× 116 0.4× 150 0.6× 176 0.8× 111 1.2k
Gwendolyn J. Stewart United States 24 650 1.0× 325 0.8× 292 1.1× 94 0.4× 140 0.6× 68 2.0k
José W.P. Govers‐Riemslag Netherlands 25 1.6k 2.6× 361 0.9× 222 0.8× 867 3.7× 240 1.1× 44 2.6k
B. G. Firkin Australia 21 1.1k 1.7× 196 0.5× 81 0.3× 260 1.1× 223 1.0× 79 1.6k
Gerald Soslau United States 19 380 0.6× 169 0.4× 51 0.2× 69 0.3× 75 0.3× 58 1.2k
Marion G. Macey United Kingdom 19 448 0.7× 67 0.2× 62 0.2× 179 0.8× 288 1.3× 41 1.4k
K Bauer United States 17 479 0.8× 123 0.3× 121 0.5× 145 0.6× 65 0.3× 46 998
Mettine H.A. Bos Netherlands 20 410 0.7× 150 0.4× 155 0.6× 125 0.5× 29 0.1× 56 975
C. Elliott Bell United States 13 309 0.5× 95 0.2× 130 0.5× 59 0.3× 147 0.7× 22 1.0k
Mark M. Udden United States 24 710 1.1× 101 0.2× 37 0.1× 674 2.9× 154 0.7× 62 2.1k

Countries citing papers authored by M.A. Lazzari

Since Specialization
Citations

This map shows the geographic impact of M.A. Lazzari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Lazzari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Lazzari more than expected).

Fields of papers citing papers by M.A. Lazzari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Lazzari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Lazzari. The network helps show where M.A. Lazzari may publish in the future.

Co-authorship network of co-authors of M.A. Lazzari

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Lazzari. A scholar is included among the top collaborators of M.A. Lazzari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Lazzari. M.A. Lazzari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gagliardi, Juan, et al.. (2026). Evaluación de los niveles plasmáticos de células progenitoras en pacientes con enfermedad coronaria crónica. Revista Argentina de Cardiología. 75(6). 429–435.
2.
Woods, Adriana Inés, A Blanco, Ana Catalina Kempfer, et al.. (2016). Factor von Willebrand y Enfermedad de von Willebrand: nuevos enfoques diagnósticos. Acta bioquímica clínica latinoamericana. 50(2). 273–289.
3.
Woods, Adriana Inés, Analía Sánchez‐Luceros, Ana Catalina Kempfer, et al.. (2011). C1272F: a novel type 2A von Willebrand’s disease mutation in A1 domain; its clinical significance. Haemophilia. 18(1). 112–116. 7 indexed citations
4.
Woods, Adriana Inés, Analía Sánchez‐Luceros, Susana Meschengieser, et al.. (2011). Diagnosis and Management ofvon Willebrand Disease in a Single Institution of Argentina. Seminars in Thrombosis and Hemostasis. 37(5). 568–575. 3 indexed citations
5.
Kempfer, Ana Catalina, et al.. (2010). VWF and ADAMTS13 behavior in estradiol-treated HUVEC. European Journal Of Haematology. 86(2). 140–147. 8 indexed citations
6.
Meschengieser, Susana, et al.. (2006). Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease. Thrombosis and Haemostasis. 96(7). 19–23. 4 indexed citations
7.
Casais, Patricia, Susana Meschengieser, Analía Sánchez‐Luceros, & M.A. Lazzari. (2005). Patients’ perceptions regarding oral anticoagulation therapy and its effect on quality of life. Current Medical Research and Opinion. 21(7). 1085–1090. 63 indexed citations
8.
Bermejo, Emilsé, et al.. (2005). Effect of nitroxyl on human platelets function. Thrombosis and Haemostasis. 94(9). 578–584. 49 indexed citations
9.
Blanco, A, et al.. (2005). Endogenous or exogenous coagulation factor level and the response to activated protein C. Thrombosis Research. 118(2). 269–273. 6 indexed citations
10.
Pozner, Roberto Gabriel, Soledad Negrotto, Lina Paola D’Atri, et al.. (2005). Prostacyclin prevents nitric oxide‐induced megakaryocyte apoptosis. British Journal of Pharmacology. 145(3). 283–292. 16 indexed citations
11.
Casais, Patricia, et al.. (2005). Mechanical heart valve prostheses and persistent lupus anticoagulant: is the thrombotic risk increased?. Blood Coagulation & Fibrinolysis. 16(3). 183–185. 1 indexed citations
12.
Bermejo, Emilsé, et al.. (2004). Assessment of platelet activation in myeloproliferative disorders with complementary techniques. Blood Coagulation & Fibrinolysis. 15(3). 235–240. 11 indexed citations
13.
Farías, C., María Marta Amaral, Ana Catalina Kempfer, et al.. (2004). von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thrombosis and Haemostasis. 92(12). 1320–1326. 96 indexed citations
14.
Rinaldi, Monica, Francesco Ria, Paola Parrella, et al.. (2001). Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.. PubMed. 61(4). 1555–62. 22 indexed citations
15.
Blanco, A & M.A. Lazzari. (1998). Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hemophilia. American Journal of Hematology. 58(3). 248–248.
16.
Meschengieser, Susana, Carlos Fondevila, María Teresa Santarelli, & M.A. Lazzari. (1998). Anticoagulación en embarazadas con prótesis valvulares mecánicas. 76(5). 407–417.
17.
Fondevila, Carlos, Susana Meschengieser, Emilsé Bermejo, & M.A. Lazzari. (1997). Persistence of low platelet adhesiveness in von Willebrand disease during pregnancy. Platelets. 8(2-3). 155–157. 2 indexed citations
18.
Kempfer, Ana Catalina, et al.. (1997). IONIZING RADIATION INCREASES CONCENTRATION OF PLASMA VON WILLEBRAND FACTOR IN CEBUS APELLA PARAGUAYANUS MONKEYS. Thrombosis Research. 88(1). 81–87. 7 indexed citations
19.
Maugeri, Norma, Emilsé Bermejo, & M.A. Lazzari. (1990). Adenosine triphosphate released from human mononuclear cells. Thrombosis Research. 59(5). 887–890. 3 indexed citations
20.
Meschengieser, Susana, A Blanco, Adriana Inés Woods, et al.. (1987). Intraplatelet levels of VWF: AG and fibrinogen in myeloproliferative disorders. Thrombosis Research. 48(3). 311–319. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abraham Majluf‐Cruz Breakdown of academic impact, for papers by Gwendolyn J. Stewart Breakdown of academic impact, for papers by José W.P. Govers‐Riemslag Breakdown of academic impact, for papers by B. G. Firkin Breakdown of academic impact, for papers by Gerald Soslau Breakdown of academic impact, for papers by Marion G. Macey Breakdown of academic impact, for papers by K Bauer Breakdown of academic impact, for papers by Mettine H.A. Bos Breakdown of academic impact, for papers by C. Elliott Bell Breakdown of academic impact, for papers by Mark M. Udden
Rankless by CCL
2026